These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 22314133)
21. Vaccine protection against simian immunodeficiency virus in monkeys using recombinant gamma-2 herpesvirus. Bilello JP; Manrique JM; Shin YC; Lauer W; Li W; Lifson JD; Mansfield KG; Johnson RP; Desrosiers RC J Virol; 2011 Dec; 85(23):12708-20. PubMed ID: 21900170 [TBL] [Abstract][Full Text] [Related]
22. Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine. Qureshi H; Ma ZM; Huang Y; Hodge G; Thomas MA; DiPasquale J; DeSilva V; Fritts L; Bett AJ; Casimiro DR; Shiver JW; Robert-Guroff M; Robertson MN; McChesney MB; Gilbert PB; Miller CJ J Virol; 2012 Feb; 86(4):2239-50. PubMed ID: 22156519 [TBL] [Abstract][Full Text] [Related]
24. Intravenous inoculation of replication-deficient recombinant vaccinia virus DIs expressing simian immunodeficiency virus gag controls highly pathogenic simian-human immunodeficiency virus in monkeys. Izumi Y; Ami Y; Matsuo K; Someya K; Sata T; Yamamoto N; Honda M J Virol; 2003 Dec; 77(24):13248-56. PubMed ID: 14645581 [TBL] [Abstract][Full Text] [Related]
25. Immunological and virological analyses of rhesus macaques immunized with chimpanzee adenoviruses expressing the simian immunodeficiency virus Gag/Tat fusion protein and challenged intrarectally with repeated low doses of SIVmac. Cervasi B; Carnathan DG; Sheehan KM; Micci L; Paiardini M; Kurupati R; Tuyishime S; Zhou XY; Else JG; Ratcliffe SJ; Ertl HC; Silvestri G J Virol; 2013 Sep; 87(17):9420-30. PubMed ID: 23804645 [TBL] [Abstract][Full Text] [Related]
26. SIV antigen immunization induces transient antigen-specific T cell responses and selectively activates viral replication in draining lymph nodes in retroviral suppressed rhesus macaques. Hu H; Gama L; Aye PP; Clements JE; Barry PA; Lackner AA; Weissman D Retrovirology; 2011 Jul; 8():57. PubMed ID: 21752277 [TBL] [Abstract][Full Text] [Related]
27. Activated CD4+CCR5+ T cells in the rectum predict increased SIV acquisition in SIVGag/Tat-vaccinated rhesus macaques. Carnathan DG; Wetzel KS; Yu J; Lee ST; Johnson BA; Paiardini M; Yan J; Morrow MP; Sardesai NY; Weiner DB; Ertl HC; Silvestri G Proc Natl Acad Sci U S A; 2015 Jan; 112(2):518-23. PubMed ID: 25550504 [TBL] [Abstract][Full Text] [Related]
28. Post-infection immunodeficiency virus control by neutralizing antibodies. Yamamoto H; Kawada M; Takeda A; Igarashi H; Matano T PLoS One; 2007 Jun; 2(6):e540. PubMed ID: 17579714 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of a self-inactivating lentiviral vector expressing simian immunodeficiency virus gag for induction of specific immune responses in vitro and in vivo. Buffa V; Negri DR; Leone P; Borghi M; Bona R; Michelini Z; Compagnoni D; Sgadari C; Ensoli B; Cara A Viral Immunol; 2006; 19(4):690-701. PubMed ID: 17201664 [TBL] [Abstract][Full Text] [Related]
30. Control of Heterologous Simian Immunodeficiency Virus SIV Singh S; Ramírez-Salazar EG; Doueiri R; Valentin A; Rosati M; Hu X; Keele BF; Shen X; Tomaras GD; Ferrari G; LaBranche C; Montefiori DC; Das J; Alter G; Trinh HV; Hamlin C; Rao M; Dayton F; Bear J; Chowdhury B; Alicea C; Lifson JD; Broderick KE; Sardesai NY; Sivananthan SJ; Fox CB; Reed SG; Venzon DJ; Hirsch VM; Pavlakis GN; Felber BK J Virol; 2018 Aug; 92(15):. PubMed ID: 29793957 [TBL] [Abstract][Full Text] [Related]
31. Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses. Burton SL; Kilgore KM; Smith SA; Reddy S; Hunter E; Robinson HL; Silvestri G; Amara RR; Derdeyn CA Proc Natl Acad Sci U S A; 2015 Aug; 112(34):10780-5. PubMed ID: 26261312 [TBL] [Abstract][Full Text] [Related]
32. Immunization of macaques with single-cycle simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge with SIVmac239. Evans DT; Bricker JE; Sanford HB; Lang S; Carville A; Richardson BA; Piatak M; Lifson JD; Mansfield KG; Desrosiers RC J Virol; 2005 Jun; 79(12):7707-20. PubMed ID: 15919923 [TBL] [Abstract][Full Text] [Related]
33. Replicating Adenovirus-SIV Immunization of Rhesus Macaques Induces Mucosal Dendritic Cell Activation and Function Leading to Rectal Immune Responses. Ko EJ; Helmold Hait S; Enyindah-Asonye G; Rahman MA; Hoang T; Robert-Guroff M Front Immunol; 2019; 10():779. PubMed ID: 31031768 [TBL] [Abstract][Full Text] [Related]
34. DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication. Boyer JD; Robinson TM; Maciag PC; Peng X; Johnson RS; Pavlakis G; Lewis MG; Shen A; Siliciano R; Brown CR; Weiner DB; Paterson Y Virology; 2005 Mar; 333(1):88-101. PubMed ID: 15708595 [TBL] [Abstract][Full Text] [Related]
35. Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting. Patterson LJ; Malkevitch N; Venzon D; Pinczewski J; Gómez-Román VR; Wang L; Kalyanaraman VS; Markham PD; Robey FA; Robert-Guroff M J Virol; 2004 Mar; 78(5):2212-21. PubMed ID: 14963117 [TBL] [Abstract][Full Text] [Related]
36. Recombinant varicella vaccines induce neutralizing antibodies and cellular immune responses to SIV and reduce viral loads in immunized rhesus macaques. Traina-Dorge V; Pahar B; Marx P; Kissinger P; Montefiori D; Ou Y; Gray WL Vaccine; 2010 Sep; 28(39):6483-90. PubMed ID: 20654666 [TBL] [Abstract][Full Text] [Related]
37. Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine. Connor RI; Montefiori DC; Binley JM; Moore JP; Bonhoeffer S; Gettie A; Fenamore EA; Sheridan KE; Ho DD; Dailey PJ; Marx PA J Virol; 1998 Sep; 72(9):7501-9. PubMed ID: 9696847 [TBL] [Abstract][Full Text] [Related]
38. Immunogenicity in pig-tailed macaques of poliovirus replicons expressing HIV-1 and SIV antigens and protection against SHIV-89.6P disease. Fultz PN; Stallworth J; Porter D; Novak M; Anderson MJ; Morrow CD Virology; 2003 Oct; 315(2):425-37. PubMed ID: 14585346 [TBL] [Abstract][Full Text] [Related]
39. Long-term control of simian immunodeficiency virus mac251 viremia to undetectable levels in half of infected female rhesus macaques nasally vaccinated with simian immunodeficiency virus DNA/recombinant modified vaccinia virus Ankara. Manrique M; Kozlowski PA; Cobo-Molinos A; Wang SW; Wilson RL; Montefiori DC; Mansfield KG; Carville A; Aldovini A J Immunol; 2011 Mar; 186(6):3581-93. PubMed ID: 21317390 [TBL] [Abstract][Full Text] [Related]
40. Significant protection against high-dose simian immunodeficiency virus challenge conferred by a new prime-boost vaccine regimen. Schell JB; Rose NF; Bahl K; Diller K; Buonocore L; Hunter M; Marx PA; Gambhira R; Tang H; Montefiori DC; Johnson WE; Rose JK J Virol; 2011 Jun; 85(12):5764-72. PubMed ID: 21490100 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]